Tag Archives: BATTLE Trial

Genomics Update: Biomarkers Help Select Personalized Oncology Medicine

At yesterday’s AACR (American Association of Cancer Research) Meeting in Washington DC researchers presented results from the Battle Trial which is a hypothesis- driven prospective study that identifies biomarkers(BM’s) to predict tumor response and thus helps select personalized therapy for lung cancer patients.Biopsy specimens were tested for ¬†eleven biomarkers from four NSCLS pathways:EGFR,KRAS,BRAF and VEGF.The […]

Comments Off Continue Reading →